Ibrahim Turker

Ibrahim Turker

Auto-generated profile, based on publicly available information

Ibrahim Turker

Dr. A. Y. Ankara Oncology Training and Research Hospital Department of Medical Oncology, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2013 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
ITIbrahim Turker
Ibrahim Turker
UUUmmugul Uyeturk
Ummugul Uyeturk
OSOzlem Uysal Sonmez
Ozlem Uysal Sonmez
BOBerna Oksuzoglu
Berna Oksuzoglu
KHKaan Helvaci
Kaan Helvaci
NZNurullah Zengin
Nurullah Zengin
A determination of circulating tumor cell (CTC) effectiveness for prediction of progression-free survival (PFS) and overall survival (OS) was conducted as an adjunct to standard treatment of care in breast cancer management. Between November 2008 and March 2009, 22 metastatic and 12 early stage breast carcinoma patients, admitted to Ankara Oncology Training and Research Hospital, were included in this prospective trial. Patients' characteristics, treatment schedules and survival data were evaluated. CTC was detected twice by CellSearch method before and 9-12 weeks after the initiation of chemotherapy. A cut-off value equal or greater than 5 cells per 7.5 ml blood sample was considered positive. All patients were female. Median ages were 48.0 (range: 29-65) and 52.5 (range: 35-66) in early stage and metastatic subgroups, respectively. CTC was positive in 3 (13.6%) patients before chemotherapy and 6 (27.3%) patients during chemotherapy in the metastatic subgroup whereas positive in only one patient in the early stage subgroup before and during chemotherapy. The median follow-up was 22.0 (range: 21-23) and 19.0 (range: 5-23) months in the early stage and metastatic groups, respectively. In the metastatic group, both median PFS and OS were significantly shorter in any time CTC positive patients compared to CTC negative patients (PFS: 4.0 vs 14.0 months, Log-Rank p=0.013; and OS: 8.0 months vs. 20.5 months, Log-Rank p<0.001). OS was affected from multiple visceral metastatic sites (p=0.055) and higher grade (p=0.044) besides CTC positivity (log rank p<0.001). Radiological response of chemotherapy was also correlated with better survival (p<0.001). As a result, CTC positivity was confirmed as a prospective marker even in a small patient population, in this single center study. Measurement of CTC by CellSearch method in metastatic breast carcinoma cases may allow indications of early risk of relapse or death with even as few as two measurements during a chemotherapy program, but this finding should be confirmed with prospective trials in larger study populations.

18 March 2015
Verified
Journal Article
Closed access
OBOznur Bal
Oznur Bal
UAUlku Yalcintas Arslan
Ulku Yalcintas Arslan
ADAyse Durnali
Ayse Durnali
UUUmmugul Uyetrk
Ummugul Uyetrk
ADAyse Demirci
Ayse Demirci
BOBerna Oksuzoglu
Berna Oksuzoglu

9 September 2014 in Breast Care
Verified
Journal Article
Closed access
PDF file
ITIbrahim Turker
Ibrahim Turker
UAUlku Y. Arslan
Ulku Y. Arslan
OYOzan Yazici
Ozan Yazici
UUUmmugul Uyeturk
Ummugul Uyeturk
BOBerna Oksuzoglu
Berna Oksuzoglu
NZNurullah Zengin
Nurullah Zengin
Background: The aim of this retrospective study was to evaluate the prognostic factors in patients operated for stage IIIC breast carcinoma who had > 10 positive axillary lymph nodes (pN3a). Patients and Methods: The medical records of 302 operated N3a breast cancer patients without distant metastasis followed up in 2 medical oncology clinics in Ankara between January 1998 and June 2013 were evaluated retrospectively. Results: The median age was 50 (21-83) years. The median follow-up time was 43 (5-191) months. The patients were divided into 4 subgroups according to hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status. There were 151 (50.0%) patients in the HR+/HER2- group, 80 (26.5%) patients in the HR+/HER2+ group, 42 (13.9%) patients in the HR-/HER2+ group, and 29 (9.6%) patients in the triple negative (TN) group. At the time of analysis, 155 (51.3%) patients had recurrent disease and 117 (38.7%) patients had died. The median disease-free survival (DFS) and overall survival (OS) times were 46.0 and 78.0 months, respectively. Both the DFS and OS in the HR+/HER2- group were longer than in the other groups (log-rank p = 0.034 and p = 0.016, respectively). Menopausal status, progesterone receptor (PgR) status, and lymph node ratio (LNR; defined as the number of positive lymph nodes compared to the total number of removed lymph nodes) were found to be independent prognostic factors (p = 0.019, p = 0.001, and p = 0.012, respectively). Conclusion: Menopausal status, PgR status, and LNR were independent prognostic factors in operated N3a breast cancer patients, who are underrepresented in breast cancer trials.

30 June 2017 in Journal of Clinical and Experimental Investigations
Verified
Journal Article
Open access
PDF file
AAAli Alkan
Ali Alkan
TKTurgut Kaçan
Turgut Kaçan
NANilüfer Avcı
Nilüfer Avcı
ITİbrahim Türker
İbrahim Türker
SKSelen Baloğlu Kaçan
Selen Baloğlu Kaçan
FŞFiliz Çay Şenler
Filiz Çay Şenler
Objective: The purpose of this study is to investigate nurses’ levels of knowledge about port catheters (PCs), define factors effecting them and to define the subjects in which more education strategies should be developed. Patients and Methods: A descriptive, cross-sectional study was carried out in cancer centers in Turkey. Participants were evaluated with structured questionnaires to assess the levels of knowledge about PCs and management strategies of PC related complications. The questions were designed to evaluate their knowledge in different subscales. Results: 363 nurses in 7 cancer centers in 4 different cities in Turkey participated in the study. While 147 (40.5%) nurses had a more than 10 years of experience, 13.8% of them had a less than 1 year of job experience in oncology. Knowledge about “Port catheter usage and complications” and “difficulties while using PC” was worse than other subscales. The effects of the job experience on knowledge showed a negative correlation between them (r= -168, p= 0.001). In addition, participants with an experience of more than 10 years have worse scores when compared with others ( 27.2±11.4 vs. 30.6±9.4, P=0.003). There was no significant difference between nurses working in a university hospital and public hospital (28.5 ± 10.9 vs. 30.4±10.4, P= 0.086). Conclusion: The study concluded that experience in the field is negatively correlated with knowledge about PCs. Nurses actively caring PCs should be routinely updated, especially about complications of PCs and management strategies of them.

21 November 2014 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
ITIbrahim Türker
Ibrahim Türker
ŞKŞeref Kömürcü
Şeref Kömürcü
AAAli Arıcan
Ali Arıcan
HDHatice Doruk
Hatice Doruk
ÖÖÖzgür Özyılkan
Özgür Özyılkan
FAFikret Arpacı
Fikret Arpacı

27 June 2014
Verified
Journal Article
Closed access
UUUmmugul Uyeturk
Ummugul Uyeturk
ITIbrahim Turker
Ibrahim Turker
OBOznur Bal
Oznur Bal
ADAyse Demirci
Ayse Demirci
OSOzlem Uysal Sonmez
Ozlem Uysal Sonmez
BOBerna Oksuzoglu
Berna Oksuzoglu